Activity record

PGDB_A066155

Assay: bindingTarget: PPIAQC: standardized
Activity overview

inhibition = 100.03 %

TargetPPIA
Time30 min
Assay / ReadoutAlphaLISA / % Inhibition
Assay IDPGDB_AS001219
PatentJP2023161027A
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C008260
Compound IDPGDB_C008260
CompoundC45
Source record IDPGDB_C008260
InChIKeyLMMVSOLKKIVDHB-RJMRIURVSA-N

Assay context

Assay IDPGDB_AS001219
Assay familybinding
Assay systemcell_based
Readout% Inhibition
TechnologyAlphaLISA
Treatment time30 min
TargetPPIA
E3Not specified

Source evidence

Patent IDJP2023161027A
Compound location

C45

C45 enlarged structureC45 location on patent page 168
Activity table
Page 100 · table start
Page 101 · table end